183
Participants
Start Date
April 3, 2018
Primary Completion Date
March 18, 2025
Study Completion Date
March 18, 2025
CC-93269
Specified dose on specified days
Local Institution - 208, Barcelona
Icahn School of Medicine at Mount Sinai Mount Sinai West, New York
Local Institution - 401, Milan
Local Institution - 303, Hamburg
Local Institution - 402, Bergamo
Local Institution - 205, Madrid
Local Institution - 106, Atlanta
Local Institution - 201, Pamplona
Local Institution - 105, Birmingham
Local Institution - 203, Salamanca
Local Institution - 204, Santander
Local Institution - 207, Valencia
Local Institution - 202, Valencia
Local Institution - 403, Meldola
Henry Ford Medical Center - New Center One, Detroit
Local Institution - 302, Heidelberg
Local Institution - 304, Tübingen
Local Institution - 505, Uppsala
Local Institution - 306, München
Local Institution - 305, Erlangen
Local Institution - 103, San Francisco
Local Institution - 101, Seattle
Local Institution - 603, Shibuya-ku
Local Institution - 602, Nagoya
Local Institution - 107, New Haven
Local Institution - 109, Boston
Local Institution - 111, Boston
Local Institution - 605, Kamakura
Local Institution - 604, Kashiwa
Local Institution - 601, Kyoto
Local Institution - 206, Barcelona
Local Institution - 504, Gothenborg
Local Institution - 502, Lund
Local Institution - 501, Stockholm
Lead Sponsor
Celgene
INDUSTRY